tVNS in Long COVID-19
RecruitingNCT06585254Phase: NAStarted 2024-11-01
Summary
A prior open label study has shown that transcutaneous vagus nerve stimulation \[tVNS\] can improve the health of some patients with postacute sequelae of SARS-CoV-2 infection (PASC), severely affecte
Eligibility
Sex
ALL
Min Age
21 Years
Max Age
70 Years
Locations
Icahn School of Medicine at Mount SinaiNew York, New York, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06585254